The R&D principle of Huaxia Bio’s Tongyansu is essentially a technological revolution in “topicalizing medical aesthetic ingredients.” It breaks the boundary between traditional skincare products and medical aesthetic injection projects, transforming “regenerative materials” originally intended only for injection into serums that can be safely applied topically through nanotechnology.

Its core R&D principles can be summarized in the following three key dimensions:

1. Core Material Innovation: Introduction of “Girl Needle” Homologous Ingredients (PCL)

• Traditional Approach: Traditional anti-aging skincare products mostly rely on chemical ingredients like Pro-Xylane and Retinol to stimulate collagen.
• Tongyansu’s Approach: Tongyansu directly introduces Polycaprolactone (PCL), a famous ingredient in the medical aesthetic field.
  • Background: PCL is the core component of the medical aesthetic injection project “Girl Needle” (e.g., Ellansé). In medical aesthetics, PCL microspheres are injected into the dermis to act as a scaffold, inducing the body’s own collagen regeneration, with effects lasting 1-2 years.
  • R&D Challenge Breakthrough: PCL was originally a high-molecular-weight polymer that could not penetrate the skin barrier; traditional processes could only use it for injections.
  • Tongyansu’s Solution: The Huaxia Bio R&D team used special polymerization control processes to process PCL into nanometer-level microspheres. These microspheres retain the biological activity of PCL to induce collagen regeneration, but their particle size is reduced to around 100 nanometers, giving them the physical basis for transdermal absorption. This achieves “medical aesthetic-like regenerative effects without surgery.”

2. Delivery System Breakthrough: Nanoliposome Encapsulation and Microfluidic Jet Technology
To allow macromolecular ingredients like PCL and peptides to truly enter the dermis, Tongyansu employs a Nanosome Delivery System combined with high-pressure microfluidic jet homogenization technology.

• Nano-encapsulation:
  • Phospholipid bilayers are used to construct “nanovesicles” that encapsulate active ingredients such as PCL microspheres, Tridecapeptide-1, and Hexapeptide-8.
  • This structure not only protects active ingredients from being enzymatically degraded by the epidermis but also uses the compatibility between liposomes and cell membranes to deceive the skin barrier (like a “Trojan Horse”), allowing smooth passage through the stratum corneum.
• Particle Size Control:
  • Through microfluidic jet technology, the diameter of the encapsulated particles is strictly controlled to be below 500 Daltons (with some core particles reaching 100 nanometers). This is the “golden size” for skin penetration, enabling direct access to the papillary dermis (approximately 120μm depth) to act directly on fibroblasts.
• Penetration Synergy:
  • The formula includes highly efficient penetration enhancers like Isosorbide Dimethyl Ether to further open skin channels, ensuring the nanospheres can penetrate deeply.

3. Mechanism of Action Innovation: Smart Sustained Release and “Scaffold” Regeneration
After entering the dermis, Tongyansu does not release all ingredients instantly but simulates the long-term mechanism of medical aesthetic fillers:

• 24-Hour Smart Sustained Release:
  • Nanoliposomes form a microcapsule network in the dermis. With changes in body temperature and skin metabolism, they continuously release active ingredients over 24 hours. This avoids high-concentration irritation and ensures continuous signaling to fibroblasts to “synthesize collagen.”
• Liquid Scaffold Effect:
  • After PCL nanospheres are distributed in the dermis, they form an invisible “liquid three-dimensional scaffold.”
  • This scaffold not only provides immediate physical support (filling depressions) but also gently stimulates surrounding tissue, initiating a benign foreign body reaction in the human body. This induces fibroblasts to secrete large amounts of Type I and Type III collagen to wrap around the microspheres.
• Long-term Maintenance:
  • As PCL naturally degrades in the body (cycle of about 3-6 months), the newly formed collagen network has already formed and replaced the position of the microspheres. This is the scientific principle behind the claim that “effects can last for 3 months after discontinuation”—what remains is not the ingredient, but your own regenerated collagen.

4. Multi-Pathway Synergy: More Than Just PCL
In addition to PCL as the core, the R&D of Tongyansu has also constructed a multi-synergy matrix to address the limitations of single ingredients:

• Dynamic Wrinkle Blocking: Compounded with Acetyl Hexapeptide-8 and Snake Venom-like Peptide to block muscle contraction at the neural signal level while collagen regenerates, solving expression lines.
• Volume Filling: Added Japanese patented Arnica Montana flower extract to promote moderate proliferation of subcutaneous fat cells, solving soft tissue loss caused by aging (such as cheek depression).
• Anti-inflammatory Repair: Added Tridecapeptide-1 and Soluble Collagen to inhibit inflammatory factors (IL-6), preventing excessive inflammation that might be triggered during the regeneration process induced by PCL, ensuring tolerance even for sensitive skin.

Summary
In short, the R&D principle of Huaxia Bio’s Tongyansu is: Using pharmaceutical-grade nanotechnology to transform medical aesthetic injection-grade “regenerative materials” (PCL) into a topical form.

It no longer merely “supplements” nutrients but “commands” skin cells to produce their own collagen through nanoscaffolds and sustained-release signals, achieving a qualitative leap from “surface application” to “structural remodeling.” This is the fundamental reason why it can surpass many international big brands and become the top of the 2026 anti-aging list.